within Pharmacolibrary.Drugs.ATC.R;

model R05DA03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.25,
    Cl             = 9.2 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,
    adminCount     = 1,
    Vd             = 0.0035,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.018500000000000003,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Hydrocodone is a semi-synthetic opioid used for the management of moderate to moderately severe pain or as an antitussive (cough suppressant). It is commonly combined with acetaminophen or ibuprofen. Hydrocodone is approved for use in several countries, including the United States, but it is a controlled substance due to its abuse potential.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic model in healthy adult subjects after oral administration.</p><h4>References</h4><ol><li><p>KuKanich, B, &amp; Spade, J (2013). Pharmacokinetics of hydrocodone and hydromorphone after oral hydrocodone in healthy Greyhound dogs. <i>Veterinary journal (London, England : 1997)</i> 196(2) 266–268. DOI:<a href=&quot;https://doi.org/10.1016/j.tvjl.2012.09.008&quot;>10.1016/j.tvjl.2012.09.008</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23098635/&quot;>https://pubmed.ncbi.nlm.nih.gov/23098635</a></p></li><li><p>Thigpen, JC, et al., &amp; Harirforoosh, S (2019). Opioids: A Review of Pharmacokinetics and Pharmacodynamics in Neonates, Infants, and Children. <i>European journal of drug metabolism and pharmacokinetics</i> 44(5) 591–609. DOI:<a href=&quot;https://doi.org/10.1007/s13318-019-00552-0&quot;>10.1007/s13318-019-00552-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31006834/&quot;>https://pubmed.ncbi.nlm.nih.gov/31006834</a></p></li><li><p>Deng, S, et al., &amp; Wen, Y (2017). Pharmacokinetics of guaifenesin, pseudoephedrine and hydrocodone in a combination oral liquid formulation, administered as single and multiple doses in healthy Chinese volunteers, and comparison with data for individual compounds formulated as Antuss®. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 47(10) 870–878. DOI:<a href=&quot;https://doi.org/10.1080/00498254.2016.1241451&quot;>10.1080/00498254.2016.1241451</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27662264/&quot;>https://pubmed.ncbi.nlm.nih.gov/27662264</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R05DA03;
